Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
People
Research units
Research output
Activities
In the media
Prizes & Grants
Search by expertise, name or affiliation
Adjusted indirect treatment comparisons of bioequivalence studies
L Gwaza
Pharmacoepidemiology and Clinical Pharmacology
Research output
:
Thesis
›
Doctoral thesis 1 (Research UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adjusted indirect treatment comparisons of bioequivalence studies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Low-middle Income Countries
100%
Indirect Treatment Comparison
100%
Bioequivalence Study
100%
Generic Drugs
66%
Comparator Product
66%
Point Estimate
50%
Indirect Comparison
33%
Switchability
33%
Pragmatic Approach
33%
Bioequivalence
33%
Regulatory Agencies
16%
Regulatory System
16%
Global Context
16%
World Health Organization
16%
Duplication
16%
Clinical Setting
16%
Reimbursement
16%
National Government
16%
Health Professionals
16%
Market Regulation
16%
Antiretroviral
16%
National Market
16%
Innovator Product
16%
High-income Countries
16%
Generic Substitution
16%
Bioequivalent
16%
Anti-tuberculosis
16%
World Health Organization Recommendations
16%
Limited Precision
16%
Product Registration
16%
Generic Switching
16%
Acceptance Limits
16%
Artemether-lumefantrine
16%
Global Harmonization
16%
Quality Medicine
16%
Interchangeable Medicines
16%
Engineering
Comparator
100%
Point Estimate
50%
Pragmatic Approach
33%
World Health Organization
33%
Acceptance Limit
16%
Global Harmonization
16%
Health Professionals
16%
Regulatory Authority
16%
Agricultural and Biological Sciences
World Health Organization
100%
Artemether/Lumefantrine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bioequivalence
100%
Antimalarial Agent
20%
Artemether Plus Benflumetol
20%